however, some individuals may experience mild side effects such as digestive discomfort
About the Expert Reviewer Kathleen Valenton, MD is a double board-certified OB/GYN at Rodeo Drive Women's Health Center in Beverly Hills, CA, with over a decade of experience in women's health
Furnished as Exhibit 99.3 to this Report on Form 6-K is the Sustainability and P-ESG Report of the Company for the year ended December 31, 2025, prepared in accordance with Section 99a (CSR) and Section 99b (Diversity) of the Danish Financial Statements Act
The primary aim was to evaluate the efficacy and safety of semaglutide compared with other anti-diabetic therapies in patients with T2DM as second-line in patients treated with metformin and as third-line in patients with metformin and SU
References Semaglutide, a glucagon-like peptide-1 receptor agonist (GLP-1 RA), is widely used for the management of type 2 diabetes mellitus (T2DM) due to its efficacy in improving glycemic control and reducing cardiovascular risk
Randomised controlled trial of fish oil supplementation on responsiveness to resistance exercise training in sarcopenic older women
